Synthaverse (WAR:SVE) ROE % Adjusted to Book Value : -0.58% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Synthaverse ROE % Adjusted to Book Value?

Synthaverse's ROE % for the quarter that ended in Sep. 2024 was -1.56%. Synthaverse's PB Ratio for the quarter that ended in Sep. 2024 was 2.67. Synthaverse's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -0.58%.

Synthaverse ROE % Adjusted to Book Value Historical Data

The historical data trend for Synthaverse's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthaverse ROE % Adjusted to Book Value Chart

Synthaverse Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.94

0.85

1.95

1.69

1.63

Synthaverse Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-2.65	5.27	-0.57	1.60	-0.58

Competitive Comparison of Synthaverse's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Synthaverse's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthaverse's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthaverse's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Synthaverse's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Synthaverse ROE % Adjusted to Book Value Calculation

Synthaverse's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.36%	/	2.67
	=	1.63%

Synthaverse's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1.56%	/	2.67
	=	-0.58%

Synthaverse ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Synthaverse's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthaverse Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthaverse SA (WAR:SVE) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

6NQ:Germany

Address

10, Uniwersytecka street, Lublin, POL, 20-029

Website

https://synthaverse.pl

Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.

Synthaverse Headlines

No Headlines